{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:26:03Z","timestamp":1762867563276,"version":"3.40.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ygyno.2018.09.006","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T06:16:37Z","timestamp":1536819397000},"page":"311-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16\/18 and FAM19A4\/miR124-2 methylation"],"prefix":"10.1016","volume":"151","author":[{"given":"Annemiek","family":"Leeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e M.F.","family":"Ebisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemieke","family":"Kasius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remko P.","family":"Bosgraaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miekel M.","family":"van de Sandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1737-2295","authenticated-orcid":false,"given":"Lise M.A.","family":"de Strooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00eblle A.M.","family":"Heideman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.F.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon F.A.G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruud L.M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Folkert J.","family":"van Kemenade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim G.V.","family":"Quint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem J.G.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.09.006_bb0005","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of cervical cancer mortality in the member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.09.006_bb0010","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(87)92695-X","article-title":"Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes","volume":"1","author":"Laara","year":"1987","journal-title":"Lancet"},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2018.09.006_bb0015","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ygyno.2018.09.006_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ygyno.2005.10.020","article-title":"Effects of HPV detection in population-based screening programmes for cervical cancer; a Dutch moment","volume":"100","author":"Bekkers","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ypmed.2014.04.011","article-title":"Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women","volume":"64","author":"Bosgraaf","year":"2014","journal-title":"Prev. Med."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ypmed.2012.01.012","article-title":"Non-participation in screening: the case of cervical cancer in Denmark","volume":"54","author":"Dugue","year":"2012","journal-title":"Prev. Med."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1586\/14737140.2014.856273","article-title":"The current position and the future perspectives of cervical cancer screening","volume":"14","author":"Bosgraaf","year":"2014","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0040","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14737140.2016.1232166","article-title":"Triage of high-risk HPV positive women in cervical cancer screening","volume":"16","author":"Ebisch","year":"2016","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0045","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.30090","article-title":"The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples","volume":"139","author":"Ebisch","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.09.006_bb0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Munoz","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.09.006_bb0055","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study","volume":"20","author":"Schiffman","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2014.08.003","article-title":"Methylation marker analysis and HPV16\/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer","volume":"135","author":"Verhoef","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2008.10.012","article-title":"Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science","volume":"112","author":"Wentzensen","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0070","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.28138","article-title":"CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease","volume":"133","author":"Bierkens","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.09.006_bb0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2018.09.006_bb0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/rmv.686","article-title":"The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening","volume":"21","author":"Schmeink","year":"2011","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0085","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/PAS.0000000000000342","article-title":"Attributing oncogenic human papillomavirus genotypes to high-grade cervical neoplasia: which type causes the lesion?","volume":"39","author":"van der Marel","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0090","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ijc.29026","article-title":"Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening","volume":"136","author":"Bosgraaf","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2018.09.006_bb0095","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(09)00540-X","article-title":"Validation of high-risk HPV tests for primary cervical screening","volume":"46","author":"Meijer","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0100","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1128\/JCM.01962-14","article-title":"Clinical evaluation of a GP5+\/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control","volume":"52","author":"Geraets","year":"2014","journal-title":"J. Clin. Microbiol."},{"issue":"Suppl. 3","key":"10.1016\/j.ygyno.2018.09.006_bb0105","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S1386-6532(09)70297-5","article-title":"High-throughput genotyping of high-risk HPV by the digene HPV genotyping LQ test using GP5+\/6+-PCR and xMAP technology","volume":"46","author":"Geraets","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/path.855","article-title":"Comparative analysis of human papillomavirus infections in cervical scrapes and biopsy specimens by general SPF(10) PCR and HPV genotyping","volume":"194","author":"Quint","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0115","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1128\/JCM.37.8.2508-2517.1999","article-title":"Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus","volume":"37","author":"Kleter","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2016.02.012","article-title":"Validation of the FAM19A4\/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women","volume":"141","author":"De Strooper","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0125","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/14737159.2016.1217157","article-title":"Management of high-risk HPV-positive women for detection of cervical (pre)cancer","volume":"16","author":"Luttmer","year":"2016","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/j.ygyno.2018.09.006_bb0130","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.09.006_bb0135","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2018.09.006_bb0140","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.31539","article-title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up","volume":"143","author":"De Strooper","year":"2018","journal-title":"Int. J. Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818312174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818312174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T08:11:04Z","timestamp":1720599064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818312174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0090825818312174"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.09.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16\/18 and FAM19A4\/miR124-2 methylation","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}